Opendata, web and dolomites

3L-HeCoMe

Advanced manufacturing process to obtain a partially Bio-Resorbable Adhesive/Non-Adhesive Triple Layer Mesh for intra-peritoneal Hernia Containment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 3L-HeCoMe project word cloud

Explore the words cloud of the 3L-HeCoMe project. It provides you a very rough idea of what is the project "3L-HeCoMe" about.

medical    bioresorption    adhesions    fs    parietal    prosthetic    global    avoiding    solutions    sales    technologies    amounts    usd    repair    hecome    market    452    hospitalization    industrial    life    anti    applicability    surfaces    solid    penetration    healthcare    quality    decreasing    iptawh    actual    materials    partial    reduce    hernias    displacement    732    qualify    fixation    36    complications    innovative    repairs    patients    hernia    operation    700    feasibility    post    constituting    considering    reducing    treatment    mechanical    substitute    tissues    wall       400    containment    md    thanks    simplified    adhesion    procedure    2019    259    mesh    innovate    surgeons    efficient    cagr    sme    final    position    3l    ing    preventing    ventral    surgery    societal    markets    500    customization    recurrence    intraperitoneal    abdominal    amount    mininvasive    million    surgical    viscera    faster    device    routes    income    chemical    giving    output    year    adhesive    instruments    oriented    operative   

Project "3L-HeCoMe" data sheet

The following table provides information about the project.

Coordinator
HERNIAMESH SRL 

Organization address
address: Via Fratelli Meliga 1/C
city: Chivasso
postcode: 10034
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.herniamesh.it
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HERNIAMESH SRL IT (Chivasso) coordinator 50˙000.00
2    TISSUEMED LIMITED UK (LEEDS) participant 0.00

Map

 Project objective

3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications still occur, namely recurrence due to prosthetic displacement and adhesions between viscera and prosthetic surfaces. Considering estimated costs for each ventral hernia repair in Europe, costs due only to recurrence amount to 36.732.000 €/year. The main aim of 3L-HeCoMe Feasibility Study(FS) is the development of an innovative process supported by enabling technologies derived from other applications and by the use of advanced materials to produce a unique medical device for the Intraperitoneal Treatment of Abdominal Wall Hernias (IPTAWH). The produced IPTAWH medical device (IPTAWH-MD) aims at preventing post-surgery problems and avoiding, or decreasing, use of mechanical surgery instruments for the mesh fixation. The IPTAWH-MD will reduce the surgical duration and costs, thanks to the following characteristics: ‐ chemical adhesive properties to parietal tissues ‐ anti-adhesion properties to viscera ‐ adequate mechanical properties, ‐ partial bioresorption. FS objectives: ‐ investigate technical development, process customization and applicability ‐ qualify 3L-HeCoMe process production output and constituting materials ‐ assess market potential and penetration routes Final users are surgeons oriented towards simplified, faster and mininvasive procedure, in the global market, which amounts to about USD 500 million and has an estimated CAGR of 7.5%, bringing to 700 million in 2019. The resulting MD will substitute actual products, giving a solid position to the SME in global markets and increasing the income, with potential sales of 259.000 – 452.000 €/year from year 1 to 5. 3L-HeCoMe addresses societal issues avoiding hernia operation recurrence, improving quality of life of patients by reducing hospitalization and reducing healthcare

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "3L-HECOME" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "3L-HECOME" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

InLineNano (2015)

In-Line Areal Surface Measurement for Micro and Nano Production

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More